| # | Drug | Count |
|---|---|---|
| 0 | TACROLIMUS | 243 |
| 1 | PREDNISONE | 227 |
| 2 | TACROLIMUS EXTENDED-RELEASE CAPSULES | 217 |
| 3 | TACROLIMUS OINTMENT 0.1% | 217 |
| 4 | MYCOPHENOLATE MOFETIL | 207 |
| 5 | METHYLPREDNISOLONE | 183 |
| 6 | METHOTREXATE SODIUM | 173 |
| 7 | RITUXIMAB | 155 |
| 8 | METHOTREXATE | 154 |
| 9 | CYCLOPHOSPHAMIDE | 152 |
| # | Drug | Count | Frequency |
|---|---|---|---|
| 0 | DARIDOREXANT | 10 | 0.0036 |
| 1 | CEFIXIME | 10 | 0.0033 |
| 2 | MICAFUNGIN SODIUM | 19 | 0.0029 |
| 3 | BUSULFAN | 45 | 0.0028 |
| 4 | MITOXANTRONE HYDROCHLORIDE | 17 | 0.0027 |
| 5 | TIGECYCLINE | 15 | 0.0024 |
| 6 | GANCICLOVIR SODIUM | 22 | 0.0021 |
| 7 | THIOTEPA | 18 | 0.0018 |
| 8 | AMPHOTERICIN B | 23 | 0.0018 |
| 9 | TACROLIMUS OINTMENT 0.1% | 217 | 0.0017 |
| # | Drug class | Count |
|---|---|---|
| 0 | Corticosteroid [EPC] | 583 |
| 1 | Alkylating Drug [EPC] | 206 |
| 2 | CD20-directed Cytolytic Antibody [EPC] | 164 |
| 3 | Folate Analog Metabolic Inhibitor [EPC] | 155 |
| 4 | Nonsteroidal Anti-inflammatory Drug [EPC] | 151 |
| 5 | Nucleoside Metabolic Inhibitor [EPC] | 149 |
| 6 | Azole Antifungal [EPC] | 120 |
| 7 | Loop Diuretic [EPC] | 108 |
| 8 | Topoisomerase Inhibitor [EPC] | 105 |
| 9 | Proton Pump Inhibitor [EPC] | 104 |
| # | Drug class | Count | Frequency |
|---|---|---|---|
| 0 | Complement C5 Inhibitor [EPC] | 1 | 0.0083 |
| 1 | CD38-directed Cytolytic Antibody [EPC] | 19 | 0.0032 |
| 2 | Echinocandin Antifungal [EPC] | 22 | 0.0027 |
| 3 | CD22-directed Immunoconjugate [EPC] | 8 | 0.0027 |
| 4 | Lipid-based Polyene Antifungal [EPC] | 28 | 0.0022 |
| 5 | Anthracycline Topoisomerase Inhibitor [EPC] | 5 | 0.0021 |
| 6 | Tetracycline-class Antibacterial [EPC] | 16 | 0.0020 |
| 7 | CD123 Interaction [EPC] | 1 | 0.0019 |
| 8 | Penem Antibacterial [EPC] | 57 | 0.0017 |
| 9 | Serotonin-4 Receptor Agonist [EPC] | 1 | 0.0015 |